Taboola’s Recent Performance and Strategic Expansion
Taboola (TBLA) closed its most recent trading session up 0.58 % at 02:19 PM Central Europe on Friday, 23 September. The share price settled at approximately USD 3.47 on the main exchanges. With a circulating supply of 252.1 million shares, the company’s market capitalisation currently stands at USD 937.4 million. In the last 24 hours, roughly USD 3.9 million worth of Taboola shares changed hands, a modest volume relative to its overall market presence. Since the close of last month, the stock has fallen 3.07 %. The 200‑day simple moving average sits at USD 4.04, and the highest price reached in the past 52 weeks was USD 5.71 on 7 July 2026, while the 52‑week low was USD 2.84 on 25 February 2026.
New Subsidiary Launches in Europe
Taboola.com Ltd. announced the creation of a wholly owned subsidiary, Taboola Europe Limited, which has commenced its offer period in mid‑September. The new entity is positioned to act as an active offeror in the European market, thereby reinforcing Taboola’s footprint within the continent’s digital advertising ecosystem. No additional regulatory filings beyond standard disclosure updates have been issued, and the company remains in compliance with current takeover code regulations.
The announcement aligns with a broader trend of activity across the sector, as several peers have recently initiated or adjusted offer periods to capture strategic opportunities. Analysts have noted that Taboola’s move reflects a deliberate strategy to consolidate its standing amidst heightened competition, while also positioning the firm to leverage growth in European digital ad spend.
Market Reactions and Comparative Peer Performance
The market’s response to Taboola’s European expansion has been measured. In the 24‑hour window following the announcement, the following peer stocks exhibited notable movements:
| Stock | 24‑Hour Change | Current Price | Market Capitalisation |
|---|---|---|---|
| Alpha Tau Medical (DRTS) | +2.98 % | USD 12.90 | USD 1.1 bn |
| Oddity Tech (ODD) | –4.89 % | USD 23.35 | USD 1.0 bn |
| Playtika (PLTK) | –0.96 % | USD 2.06 | USD 785.7 mn |
| Formula (FORTY.TA) | +3.57 % | ILS 388.6 | ILS 1.6 bn |
| Cognyte Software (CGNT) | +5.90 % | USD 9.28 | USD 689 mn |
Alpha Tau Medical’s uptick follows its announcement of a memorandum of understanding with Samsung Medical Center in Seoul, which could open new avenues for its Alpha DaRT therapy in oncology. Oddity Tech’s decline comes despite a high price‑earnings ratio of 67.91, suggesting market caution about its valuation. Playtika and Cognyte Software experienced modest movements, reflecting broader industry sentiment.
Company Overview
Taboola.com Ltd. is headquartered in Herzliya, Israel, and operates as a global advertising agency. Its proprietary platform, driven by artificial intelligence, delivers content recommendations across websites, devices, and mobile applications, thereby enhancing user engagement and monetising digital properties. The company’s continued investment in technology and strategic expansions—such as the recent launch of Taboola Europe Limited—underscore its commitment to maintaining a leadership position in the competitive digital advertising landscape.
